home : resources [ videos :: patient education :: prostate fax :: publications :: links :: vitamin order form :: ]

Preview our resource videos below.  Per DVD cost is $30.00 USD plus shipping and handling.  If you are interested in pre-ordering any of our videos in DVD format, please fill out the form below and we will contact you promptly. Available in late May 2006.
 
A New Perspective: Look Before You Leap -Mark Scholz, MD
Prostate cancer treatment is rapidly changing. More and more, the disease is being separated into two widely disparate categories: a chronic form that is not life-threatening and an aggressive type that requires combination treatment. This lecture, by Mark Scholz, MD, focuses on the chronic form of the disease, describing how men can safely forgo immediate radical treatment. This is achieved by a process of close monitoring called Active Surveillance. A third type of prostate cancer falls between the two extremes of chronic and aggressive—it is called intermediate risk. Management of Intermediate Risk prostate cancer with Testosterone Inactivating Pharmaceuticals (TIP) instead of radical therapy is also covered in this lecture.

Other DVDs in this series include: Systemic Therapies for Prostate Cancer by Richard Lam, MD and Testosterone Independent Prostate Cancer by Mark Scholz, MD.

Systemic Treatments for Prostate Cancer -Richard Lam, MD
Why are medicines for a “localized” cancer needed?

Prostate cancer, contrary to popular belief, is often associated with systemic metastasis—microscopic cancer outside of the gland. Clear bone scans and CT scans can be misleading since they are unable to “see” microscopic disease. Microscopic metastasis may be present if the PSA is rising quickly, multiple biopsy cores are involved with cancer, the Gleason score is greater than 7, the PSA is above 10, or a large nodule is present in the prostate. Men with these adverse risk features receive little, if any benefit when primary therapy consists of prostate surgery or radiation alone.

This lecture, by Richard Lam, MD, focuses on identifying men likely to have micro-metastasis and discusses possible treatments. Systemic therapies include testosterone inactivating pharmaceuticals (TIP), radiation therapy, Taxotere® (docetaxel), immune-based compounds, targeted drugs, and experimental agents.

Other DVDs in this series include: Testosterone Independent Prostate Cancer and A New Perspective for Early Stage Disease: Look Before You Leap both by Mark Scholz, MD.

Testosterone Independent Prostate Cancer -Mark Scholz, MD
Testosterone blockade can control prostate cancer for years. However, when the disease becomes resistant, additional therapy is required. Timing can be crucial—it is important to avoid delaying therapy. Early initiation of treatment increases its effectiveness. This lecture, by Mark Scholz, MD, explains how to spot the first signs of testosterone resistance so that treatment can start immediately. The principles and proper methods for selecting appropriate therapies are reviewed. Methods for reducing the side-effects of treatment and for handling common emergencies are addressed.

Other DVDs in this series include: A New Perspective: Look Before you Leap by Mark Scholz, MD and Systemic Treatments for Prostate Cancer by Richard Lam, MD.

 
Name:


Email:


Phone:
() -

Which videos are you interested in purchasing?
A New Perspective: Look Before You Leap price: $30 USD each+S/H
Systemic Treatments for Prostate Cancer price: $30 USD each+S/H
Testosterone Independent Prostate Cancer price: $30 USD each+S/H